Significant alterations of serum cytokine levels in patients with Peyronie's disease

International Braz J Urol

Volumn 34, Issue 4, 2008, Pages 457-466

  Zimmermann, Reinhold P ^a   Feil, Gerhard ^b   Bock, Conny ^b   Hoeltl, Lorenz ^a   Stenzl, Arnulf ^b  

^a ELISABETHINEN HOSPITAL   (Austria)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cytokines; IFN ; IL 6; Pathophysiology; Peyronie's disease; TGF ; TNF

Indexed keywords

EID: 56349156155     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382008000400008     Document Type: Article

References (32)

1. Nöske HD, Hauck EW: Morbus Lapeyronie aus historischer Sicht. Aktuel Urol. 2001; 32 (Suppl 1): 2-6.
2. Smith BH: Peyronie's disease. Am J Clin Pathol. 1966; 45: 670-8.
3. Smith BH: Subclinical Peyronie's disease. Am J Clin Pathol. 1969; 52: 385-90.
4. Devine CJ Jr, Somers KD, Jordan SG, Schlossberg SM: Proposal: trauma as the cause of the Peyronie's lesion. J Urol. 1997; 157: 285-90.
5. Leffell MS: Is there an immunogenetic basis for Peyronie's disease? J Urol. 1997; 157: 295-7.
6. Bichler KH, Lahme S, Mattauch W, Petri E: Collagen metabolism in induratio penis plastica (IPP). Urologe A. 1998; 37: 306-11.
7. Somers KD, Sismour EN, Wright GL Jr, Devine CJ Jr, Gilbert DA, Horton CE: Isolation and characterization of collagen in Peyronie's disease. J Urol. 1989; 141: 629-31.
8. Mammaev SN, Lukina EA, Shul'pekova IuO, Levina AA, Ivashkin VT: Cytokine regulation of liver inflammation and fibrosis during chronic hepatic diseases. Klin Lab Diagn. 2001; 12: 37-40.
9. Martinet Y, Menard O, Vaillant P, Vignaud P, Vignaut JM, Martinet N: Cytokines in human lung fibrosis. Arch Toxicol Suppl. 1996; 18: 127-39.
10. Eddy AA: Molecular basis of renal fibrosis. Pediatr Nephrol. 2000; 15: 290-301.
11. Xie MJ, Motoo Y, Su SB, Sawabu N: Expression of tumor necrosis factor-alpha, interleukin-6, and interferon-gamma in spontaneous chronic pancreatitis in the WBN/Kob rat. Pancreas. 2001; 22: 400-8.
12. Haque MF, Meghji S, Khitab U, Harris M: Oral submucous fibrosis patients have altered levels of cytokine production. J Oral Pathol Med. 2000; 29: 123-8.
13. Mills BG, Frausto A, Brien E: Cytokines associated with the pathophysiology of aggressive fibromatosis. J Orthop Res. 2000; 18: 655-62.
14. Feil G, Bichler KH, Lahme S, Götz T: Investigations on cytokines in serum of patients with Peyronie's disease. Akt Urol. 2001; 32 (Suppl 1): 33-6.
15. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC: Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 2000; 35: 644-52.
16. Tredget EE, Wang R, Shen Q, Scott PG, Ghahary A: Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J Interferon Cytokine Res. 2000; 20: 143-51.
17. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H: Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology. 2000; 32: 247-55.
18. Hauck EW, Hauptmann A, Schmelz HU, Bein G, Weidner W, Hackstein H: Prospective analysis of single nucleotide polymorphisms of the transforming growth factor beta-1 gene in Peyronie's disease. J Urol. 2003; 169: 369-72.
19. Lin CS, Lin G, Wang Z, Maddah SA, Lue TF: Upregulation of monocyte chemoattractant protein 1 and effects of transforming growth factor-beta 1 in Peyronie's disease.Biochem Biophys Res Commun. 2002; 295: 1014-9.
20. El-Sakka AI, Hassoba HM, Chui RM, Bhatnagar RS, Dahiya R, Lue TF: An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol. 1997; 158: 2284-90.
21. Bivalacqua TJ, Diner EK, Novak TE, Vohra Y, Sikka SC, Champion HC, et al.: A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. J Urol. 2000; 163: 1992-8.
22. Davila HH, Ferrini MG, Rajfer J, Gonzalez-Cadavid NF: Fibrin as an inducer of fibrosis in the tunica albuginea of the rat: a new animal model of Peyronie's disease. BJU Int. 2003; 91: 830-8.
23. Missale G, Ferrari C, Fiaccadori F: Cytokine mediators in acute inflammation and chronic course of viral hepatitis. Ann Ital Med Int. 1995; 10: 14-8.
24. Bonfield TL, Konstan MW, Berger M: Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol. 1999; 104: 72-8.
25. Osika E, Cavaillon JM, Chadelat K, Boule M, Fitting C, Tournier G, et al.: Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. Eur Respir J. 1999; 14: 339-46.
26. Lu KC, Jaramillo A, Lecha RL, Schuessler RB, Aloush A, Trulock EP, et al.: Interleukin-6 and interferongamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation. Transplantation. 2002; 74: 1297-302.
27. Elborn JS, Norman D, Delamere FM, Shale DJ: In vitro tumor necrosis factor-alpha secretion by monocytes from patients with cystic fibrosis. Am J Respir Cell Mol Biol. 1992; 6: 207-11.
28. Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM: Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation. Laryngoscope. 2002; 112: 1627-34. Erratum in: Laryngoscope. 2003; 4: 291.
29. Wang X, Chen YX, Xu CF, Zhao GN, Huang YX, Wang QL: Relationship between tumor necrosis factor-alphaand liver fibrosis. World J Gastroenterol. 1998; 4: 18.
30. Wojnarowski C, Frischer T, Hofbauer E, Grabner C, Mosgoeller W, Eichler I, et al.: Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation. Eur Respir J. 1999; 14: 1136-44.
31. Oldroyd SD, Thomas GL, Gabbiani G, El Nahas AM: Interferon-gamma inhibits experimental renal fibrosis. Kidney Int. 1999; 56: 2116-27.
32. Takahara T, Sugiyama K, Zhang LP, Ando O, Fujii M, Yata Y, et al.: Cotreatment with interferon-alpha and -gamma reduces liver fibrosis in a rat model. Hepatol Res. 2004; 28: 146-154.